Literature DB >> 8697406

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.

L R Schwarz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8697406     DOI： 10.1002/(SICI)1097-0142(19960801)78:3<566::AID-CNCR27>3.0.CO;2-W

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in the first-line setting for Chinese patients with metastatic nasopharyngeal carcinoma.

Authors:  Chaohui Jin; Hanrui Zheng; Mei Zhan; Feng Wen; Ting Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-12       Impact factor: 2.503

2.  Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma.

Authors:  Ying Jin; Yan-Xia Shi; Xiu-Yu Cai; Xi-Ya Xia; Yu-Chen Cai; Ye Cao; Wei-Dong Zhang; Wei-Han Hu; Wen-Qi Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-10       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.